908 Devices Inc. – NASDAQ:MASS
Founder-led company
908 Devices stock price today
$6.21
+3.95
+174.78%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
908 Devices stock price monthly change
-57.52%
month
908 Devices stock price quarterly change
-57.52%
quarter
908 Devices stock price yearly change
-77.60%
year
908 Devices key metrics
Market Cap | 64.94M |
Enterprise value | 108.22M |
P/E | -7.79 |
EV/Sales | 2.30 |
EV/EBITDA | -3.40 |
Price/Sales | 5.91 |
Price/Book | 1.45 |
PEG ratio | 0.21 |
EPS | -1.07 |
Revenue | 50.73M |
EBITDA | -39.93M |
Income | -34.78M |
Revenue Q/Q | 5.31% |
Revenue Y/Y | 5.62% |
Profit margin | -71.64% |
Oper. margin | -75.52% |
Gross margin | 55.54% |
EBIT margin | -75.52% |
EBITDA margin | -78.72% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for free908 Devices stock price history
908 Devices stock forecast
908 Devices financial statements
| Jun 2023 | 12.09M | -9.34M | -77.28% |
|---|---|---|---|
| Sep 2023 | 14.29M | -7.09M | -49.61% |
| Dec 2023 | 14.35M | -7.42M | -51.77% |
| Mar 2024 | 9.99M | -10.91M | -109.27% |
| Mar 2024 | 9.99M | -10.91M | -109.27% |
|---|---|---|---|
| Sep 2025 | 16.67M | -8.74M | -52.44% |
| Oct 2025 | 22.18M | -6.97M | -31.46% |
| Dec 2025 | 24.68M | -5.99M | -24.29% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 210830000 | 36.37M | 17.25% |
|---|---|---|---|
| Sep 2023 | 208475000 | 38.54M | 18.49% |
| Dec 2023 | 202981000 | 37.49M | 18.47% |
| Mar 2024 | 189791000 | 32.89M | 17.33% |
| Jun 2023 | -7.88M | -19.93M | -401K |
|---|---|---|---|
| Sep 2023 | -4.6M | -9.91M | -248K |
| Dec 2023 | -1.93M | 4.63M | 95K |
| Mar 2024 | -9.35M | -5.78M | -1.29M |
908 Devices alternative data
| Aug 2023 | 227 |
|---|---|
| Sep 2023 | 227 |
| Oct 2023 | 227 |
| Nov 2023 | 227 |
| Dec 2023 | 227 |
| Jan 2024 | 227 |
| Feb 2024 | 227 |
| Mar 2024 | 230 |
| Apr 2024 | 230 |
| May 2024 | 230 |
| Jun 2024 | 230 |
| Jul 2024 | 230 |
908 Devices other data
30.11%
-38.57%
of MASS is owned by hedge funds
50
-39
9.48M
-12.22M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 0 | 4470 |
| Dec 2023 | 0 | 31580 |
| Feb 2024 | 0 | 33669 |
| May 2024 | 50000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | KNOPP KEVIN J. director, officer.. | Stock Option (Right to Buy) | 158,044 | $1.67 | $263,143 | ||
Option | KNOPP KEVIN J. director, officer.. | Common Stock | 110,626 | $1.58 | $174,789 | ||
Option | KNOPP KEVIN J. director, officer.. | Common Stock | 47,418 | $1.75 | $82,982 | ||
Option | BROWN CHRISTOPHER D. officer: Chief Product Officer | Common Stock | 6,328 | $1.58 | $9,998 | ||
Option | BROWN CHRISTOPHER D. officer: Chief Product Officer | Stock Option (Right to Buy) | 6,328 | $1.58 | $9,998 | ||
Option | CRANDELL KEITH director, 10 percent owner: | Common Stock | 7,777 | $0 | $8 | ||
Option | CRANDELL KEITH director, 10 percent owner: | Restricted Stock Unit | 7,777 | N/A | N/A | ||
Option | SPOTO MARK director | Common Stock | 7,777 | $0 | $8 | ||
Option | SPOTO MARK director | Restricted Stock Unit | 7,777 | N/A | N/A | ||
Option | HRUSOVSKY E KEVIN director | Common Stock | 7,777 | $0 | $8 |
| Quarter | Transcript |
|---|---|
| Q1 2024 30 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q1 2023 12 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of 908 Devices stock today?
One share of 908 Devices stock can currently be purchased for approximately $6.21.
-
When is 908 Devices's next earnings date?
Unfortunately, 908 Devices's (MASS) next earnings date is currently unknown.
-
Does 908 Devices pay dividends?
No, 908 Devices does not pay dividends.
-
How much money does 908 Devices make?
908 Devices has a market capitalization of 64.94M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.21% to 50.23M US dollars.
-
What is 908 Devices's stock symbol?
908 Devices Inc. is traded on the NASDAQ under the ticker symbol "MASS".
-
What is 908 Devices's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of 908 Devices?
Shares of 908 Devices can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are 908 Devices's key executives?
908 Devices's management team includes the following people:
- Dr. Kevin J. Knopp Ph.D. Co-Founder, Chief Executive Officer, Pres & Director(age: 52, pay: $371,750)
- Mr. Michael S. Turner Esq., J.D. Vice President, Sec. & Gen. Counsel(age: 58, pay: $97,840)
-
Is 908 Devices founder-led company?
Yes, 908 Devices is a company led by its founder Dr. Kevin J. Knopp Ph.D..
-
How many employees does 908 Devices have?
As Jul 2024, 908 Devices employs 230 workers.
-
When 908 Devices went public?
908 Devices Inc. is publicly traded company for more then 4 years since IPO on 18 Dec 2020.
-
What is 908 Devices's official website?
The official website for 908 Devices is 908devices.com.
-
Where are 908 Devices's headquarters?
908 Devices is headquartered at 645 Summer Street, Boston, MA.
-
How can i contact 908 Devices?
908 Devices's mailing address is 645 Summer Street, Boston, MA and company can be reached via phone at 857 254 1500.
908 Devices company profile:
908 Devices Inc.
908devices.comExchange:
NASDAQ
Full time employees:
230
Industry:
Medical - Devices
Sector:
Healthcare
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
645 Summer Street
Boston, MA 02210
Boston, MA 02210
CIK: 0001555279
ISIN: US65443P1021
CUSIP: 65443P102
